{
  "question_stem": {
    "en": "A 6-year-old boy is brought to the clinic due to recurrent nosebleeds over the last couple of weeks. The patient has no chronic medical conditions and takes no medications. Vital signs are normal. On physical examination, there is conjunctival pallor. The nares have dried, crusted blood with no active bleeding. The oropharynx is clear. Neck examination shows enlarged, palpable lymph nodes bilaterally. Cardiopulmonary examination is unremarkable. The abdomen is soft and nontender, with the liver measuring 4 cm below the costal margin. There are scattered petechiae along the trunk. Complete blood count is as follows: {{exhibit_1}}\n\nFlow cytometry of the peripheral blood demonstrates a distinct population of cells that express terminal deoxynucleotidyl transferase (TdT), CD10, and CD19. Myeloperoxidase (MPO) is negative.",
    "zh": "一名6岁男孩因过去几周反复鼻出血而被带到诊所就诊。患者无慢性病史，未服用任何药物。生命体征正常。体格检查显示结膜苍白。鼻孔有干燥的血痂，无活动性出血。口咽部清晰。颈部检查显示双侧淋巴结肿大、可触及。心肺检查无异常。腹部柔软无压痛，肝脏测量在肋骨下缘 4 厘米处。躯干上有散在的瘀点。全血细胞计数如下：{{exhibit_1}}\n\n外周血的流式细胞术显示一组独特的细胞，表达末端脱氧核苷酸转移酶 (TdT)、CD10 和 CD19。髓过氧化物酶 (MPO) 呈阴性。"
  },
  "question": {
    "en": "Which of the following is the most likely diagnosis?",
    "zh": "以下哪项是最可能的诊断？"
  },
  "options": {
    "A": {
      "en": "Acute promyelocytic leukemia",
      "zh": "急性早幼粒细胞白血病"
    },
    "B": {
      "en": "B-lymphoblastic leukemia",
      "zh": "B 淋巴细胞白血病"
    },
    "C": {
      "en": "Disseminated Burkitt lymphoma",
      "zh": "弥漫性伯基特淋巴瘤"
    },
    "D": {
      "en": "Mature T-cell leukemia",
      "zh": "成熟 T 细胞白血病"
    },
    "E": {
      "en": "T-lymphoblastic leukemia",
      "zh": "T 淋巴细胞白血病"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "This child has acute lymphoblastic leukemia (lymphoid origin), and signs of bone marrow failure (e.g., pallor from anemia, bleeding/petechiae from thrombocytopenia). These findings are concerning for **acute leukemia**, which occurs due to clonal expansion of hematopoietic progenitor cells (ie, blast cells). Blasts may be either lymphoid or myeloid in origin. Immunophenotyping (eg, flow cytometry) is used to characterize blast cells and classify acute leukemia.\n\nThis patient's cells are lymphoid in origin. Lymphoid cells typically lack myeloperoxidase (MPO), an enzyme involved in microbial killing by myeloid derivatives (eg, neutrophils). Immature lymphocytes (lymphoblasts) can be differentiated from mature lymphocytes by the presence of **terminal deoxynucleotidyl transferase (TdT)**. TdT is a DNA polymerase involved in V(D)J recombination, which generates antigen receptor diversity during early lymphoid maturation. Therefore, this patient has **acute lymphoblastic leukemia (ALL)**.\n\nALL can be subdivided into B-lymphoblastic leukemia (B-ALL) or T-lymphoblastic leukemia (T-ALL) based on the following markers:\n\n*   B lymphoblasts: CD10, CD19, CD20, CD22, CD79a (typically CDs ≥10)\n*   T lymphoblasts: CD2, CD3, CD4, CD5, CD7, CD8 (typically CDs <10)\n\nThis patient's cells express both CD10 and CD19, findings consistent with B-ALL.\n\n(Choice A) Acute promyelocytic leukemia (APML), a type of acute myeloid leukemia, can also present with bone marrow failure. However, APML would not express TdT, CD19, and CD10. Blast features that indicate a myeloid lineage include the expression of MPO and presence of Auer rods (needle-like cytoplasmic structures representing fused granules).\n\n(Choice C) Burkitt lymphoma can present with lymphadenopathy and disseminated disease, including bone marrow failure. Although the malignant cells express B-cell markers (eg, CD19), they do not express TdT because the cell of origin is a mature, not a progenitor, B cell.\n\n(Choice D) Mature T-cell leukemia is derived from mature or postthymic T cells, and immunophenotyping would reveal the presence of T-cell markers (eg, CD3) and the absence of TdT. Moreover, this is an uncommon neoplasm typically seen in adults, not young children.\n\n(Choice E) Immunophenotyping of cells in T-ALL, which typically presents in adolescents with a mediastinal mass, would show expression of TdT but would also express T-cell, not B-cell, markers.\n\nEducational objective:\nAcute lymphoblastic leukemia typically presents with signs/symptoms of bone marrow failure (eg, bleeding due to thrombocytopenia). Immunophenotyping by flow cytometry establishes the specific subtype; B-lymphoblastic leukemia shows expression of terminal deoxynucleotidyl transferase (TdT) (marker expressed in lymphoblasts) and B-cell markers (eg, CD10, CD19). {{exhibit_2}} {{exhibit_3}} {{exhibit_4}}",
    "zh": "该患儿患有急性淋巴细胞白血病（淋巴细胞来源），并有骨髓衰竭的征象（例如，贫血引起的苍白、血小板减少症引起的出血/瘀点）。这些发现提示**急性白血病**，其发生是由于造血祖细胞（即，原始细胞）的克隆性增殖所致。原始细胞可能起源于淋巴细胞或髓细胞。免疫分型（例如，流式细胞术）用于表征原始细胞和对急性白血病进行分类。\n\n该患者的细胞起源于淋巴细胞。淋巴细胞通常缺乏髓过氧化物酶 (MPO)，这是一种参与髓系衍生物（例如，中性粒细胞）杀灭微生物的酶。未成熟的淋巴细胞（淋巴母细胞）可以通过**末端脱氧核苷酸转移酶 (TdT)** 的存在与成熟的淋巴细胞区分开来。TdT 是一种参与 V(D)J 重组的 DNA 聚合酶，可在早期淋巴细胞成熟过程中产生抗原受体多样性。因此，该患者患有**急性淋巴细胞白血病 (ALL)**。\n\nALL 可根据以下标记物细分为 B 淋巴细胞白血病 (B-ALL) 或 T 淋巴细胞白血病 (T-ALL)：\n\n*   B 淋巴母细胞：CD10、CD19、CD20、CD22、CD79a（通常 CD ≥10）\n*   T 淋巴母细胞：CD2、CD3、CD4、CD5、CD7、CD8（通常 CD <10）\n\n该患者的细胞表达 CD10 和 CD19，这些发现与 B-ALL 一致。\n\n（选项 A）急性早幼粒细胞白血病 (APML) 是一种急性髓细胞白血病，也可表现为骨髓衰竭。然而，APML 不会表达 TdT、CD19 和 CD10。表明髓系谱系的原始细胞特征包括 MPO 的表达和 Auer 小体的存在（代表融合颗粒的针状细胞质结构）。\n\n（选项 C）伯基特淋巴瘤可表现为淋巴结肿大和播散性疾病，包括骨髓衰竭。尽管恶性细胞表达 B 细胞标志物（例如，CD19），但它们不表达 TdT，因为起源细胞是成熟的 B 细胞，而不是祖细胞。\n\n（选项 D）成熟 T 细胞白血病源自成熟或胸腺后 T 细胞，免疫分型将显示 T 细胞标志物（例如，CD3）的存在和 TdT 的缺失。此外，这是一种不常见的肿瘤，通常见于成人，而不是幼儿。\n\n（选项 E）T-ALL 细胞的免疫分型（通常在青少年中表现为纵隔肿块）将显示 TdT 的表达，但也会表达 T 细胞而不是 B 细胞标志物。\n\n教育目标：\n急性淋巴细胞白血病通常表现为骨髓衰竭的体征/症状（例如，血小板减少症引起的出血）。通过流式细胞术进行的免疫分型确定了特定的亚型；B 淋巴细胞白血病显示末端脱氧核苷酸转移酶 (TdT)（淋巴母细胞中表达的标志物）和 B 细胞标志物（例如，CD10、CD19）的表达。{{exhibit_2}} {{exhibit_3}} {{exhibit_4}}"
  },
  "summary": {
    "en": "This question tests knowledge of acute leukemia, specifically acute lymphoblastic leukemia (ALL), including its presentation, diagnosis via flow cytometry, and differentiation into B-ALL and T-ALL based on cell markers.\n\nTo solve this question, recognize the signs of bone marrow failure (pallor, petechiae), interpret the flow cytometry results (TdT+, CD10+, CD19+), and apply the knowledge of B-ALL markers to arrive at the correct diagnosis.",
    "zh": "此题考察对急性白血病的认识，特别是急性淋巴细胞白血病 (ALL)，包括其表现、通过流式细胞术诊断以及根据细胞标志物将其区分为 B-ALL 和 T-ALL。\n\n要解决此问题，需要识别骨髓衰竭的体征（苍白、瘀点），解释流式细胞术结果（TdT+、CD10+、CD19+），并应用 B-ALL 标志物的知识来得出正确的诊断。"
  },
  "tags": "Acute lymphoblastic leukemia; B-lymphoblastic leukemia; Leukemia; Bone marrow failure; Flow cytometry; TdT; CD10; CD19; Hematology; Oncology",
  "category": "Blood",
  "question_id": "1571",
  "has_exhibits": true,
  "exhibit_count": 4,
  "exhibit_files": [
    "image1.jpg",
    "image2.jpg",
    "image3.jpg",
    "image4.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\Blood 23\\1571",
  "extracted_at": "2025-11-05T11:26:07.931742",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T16:28:23.873917",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}